Bulletin
Investor Alert

Global Blood Therapeutics Inc.

NAS: GBT

GO
/marketstate/country/us

After Hours

GBT
/zigman2/quotes/206019615/composite

$

61.20

Change

+0.05 +0.07%

Volume

Volume 2,466

Feb 27, 2020, 6:54 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/206019615/composite

Today's close

$ 65.22

$ 61.16

Change

-4.07 -6.23%

Day low

Day high

$57.81

$63.78

Open
Open: 62.00

52 week low

52 week high

$44.17

$87.54

Open

Market cap

$3.93B

Average volume

886,869

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-4.55

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/gbt

MarketWatch News on GBT

  1. Global Blood Therapeutics downgraded to hold from buy at SunTrust RH

    8:04 a.m. Jan. 31, 2020

    - Tomi Kilgore

  2. Global Blood Therapeutics stock price target cut to $75 from $110 at SunTrust RH

    8:04 a.m. Jan. 31, 2020

    - Tomi Kilgore

  3. Global Blood Therapeutics stock price target raised to $100 from $90 at SunTrust RH

    6:19 a.m. Oct. 14, 2019

    - Tomi Kilgore

  4. Here’s your guide to the upcoming biotechnology takeover wave

    4:48 p.m. Jan. 15, 2019

    - Michael Brush

  5. Charting a bull-trend pullback, S&P 500 hesitates at major resistance

    10:54 a.m. Aug. 23, 2018

    - Michael Ashbaugh

  6. Global Blood Therapeutics says met with FDA on potential accelerated approval of treatment

    6:32 a.m. June 27, 2018

    - Ciara Linnane

  7. Global Blood Therapeutics reports positive data in trial of sickle cell disease treatment

    6:32 a.m. June 27, 2018

    - Ciara Linnane

  8. Global Blood Therapeutics shares halted premarket for news

    6:26 a.m. June 27, 2018

    - Ciara Linnane

  9. Global Blood Therapeutics stock price target raised to $91 from $50 at Instinet

    10:24 a.m. Dec. 11, 2017

    - Tomi Kilgore

  10. Loading more headlines...
/news/nonmarketwatch/company/us/gbt

Other News on GBT

  1. Global Blood Therapeutics (GBT) Receives a Buy from Wedbush

    1:19 p.m. Today

    - SmarterAnalyst

  2. Global Blood (GBT) Q4 Earnings Miss, Voxelotor Gets FDA Nod

    9:10 a.m. Today

    - Zacks.com

  3. Global Blood Therapeutics (GBT) Receives a Buy from H.C. Wainwright

    8:54 a.m. Today

    - SmarterAnalyst

  4. Global Blood Therapeutics (GBT) Receives a Buy from William Blair

    5:04 a.m. Today

    - SmarterAnalyst

  5. Notable earnings after Wednesday's close

    5:35 p.m. Feb. 25, 2020

    - Seeking Alpha

  6. Global Blood Therapeutics Q4 2019 Earnings Preview

    5:35 p.m. Feb. 25, 2020

    - Seeking Alpha

  7. Global Blood Therapeutics (GBT) Receives a Buy from Nomura

    11:09 a.m. Feb. 19, 2020

    - SmarterAnalyst

  8. Global Blood warns on impact of coronavirus outbreak

    9:42 a.m. Feb. 14, 2020

    - Seeking Alpha

  9. IPO Update: Beam Therapeutics Proposes IPO Terms

    3:15 p.m. Jan. 27, 2020

    - Seeking Alpha

  10. The Cutting Edge Of Systematic Investing

    12:48 p.m. Jan. 21, 2020

    - Seeking Alpha

  11. 7 Stocks That Are Screaming Buys Right Now

    8:44 a.m. Jan. 9, 2020

    - InvestorPlace.com

  12. Biotech Bonanza: 2020 Outlook In An Election Year

    4:15 p.m. Jan. 8, 2020

    - Seeking Alpha

  13. 7 Stocks That Are Screaming Buys Right Now

    12:09 p.m. Jan. 6, 2020

    - InvestorPlace.com

  14. Stocks To Watch: Key 2020 Events And Catalysts

    8:22 a.m. Jan. 1, 2020

    - Seeking Alpha

  15. Loading more headlines...

Earnings Announcement

/news/pressrelease/company/us/gbt

Press Releases on GBT

  1. GBT Announces New Employment Inducement Grants

    8:00 a.m. Feb. 3, 2020

    - GlobeNewswire

  2. GBT Announces New Employment Inducement Grants

    8:00 a.m. Feb. 3, 2020

    - GlobeNewswire

  3. Hemoglobinopathy Market Will Reach US$12 Billion Globally, in 2026

    12:58 a.m. Jan. 28, 2020

    - Global QYResearch

  4. Loading more headlines...

Rates »

Link to MarketWatch's Slice.